Randomized, double-blind, split-side, comparison study of moisturizer containing MAS064D and 1% hydrocortisone in the treatment of infantile seborrheic dermatitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20160819001

Enrollment

Unknown

Registered

2016-08-19

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children less than 1 year old seborrheic dermatitis MAS064D&#44

Interventions

apply twice daily to assigned side of face

Experimental Device

MAS064D

Eligibility

Sex/Gender

All

Age

2 Weeks to 1 Years

Inclusion criteria

Inclusion criteria: children, less than 1 year old, with seborrheic dermatitis who did not receive any treatment within 2 weeks

Exclusion criteria

Exclusion criteria: children with infection

Design outcomes

Primary

Measure	Time frame
Clinical improvement 28 days Scoring system	—

Secondary

Measure	Time frame
flare free period 28 days scoring system,safety of products 28 days clinical evaluation	—

Countries

Thailand

Contacts

Public ContactSiriwan Wananukul

Chulalongkorn University

siriwanwananukul@yahoo.com022564951

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Randomized&#44; double&#45;blind&#44; split&#45;side&#44; comparison study of moisturizer containing MAS064D and 1% hydrocortisone in the treatment of infantile seborrheic dermatitis